Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin from today

The observer-blind, randomised controlled study to determine the safety and immunogenicity of #39;#39;Covishield#39;#39; on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.

from Moneycontrol Latest News https://ift.tt/2ErH5vX